ARENA PHARMACEUTICAL STOCK CLIMBS

Shares of Arena Pharmaceuticals Inc. rose Wednesday morning as UBS initiated coverage with a "Buy 2" rating, citing the company's pipeline of drug candidates. MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20060601&ID=5763665)